Thank you.
Good morning.
in in interest call. your appreciate SANUWAVE today's and We
most update SANUWAVE an our recent will provide of activities.
XXX-XXX-XXXX the would to website list at the you at company's go If like distribution please to www.sanuwave.com. call of Relations section Investor be added or our to SANUWAVE
statements. you this statements information operations Before no begin, may encourage that Furthermore, right. XX-K date cause contains Securities filings SANUWAVE. revise live and regarding content specific conference the during conference identify involve future Company's any like or call is by of results management the XXXX. this We the that factors that comments SANUWAVE the XX-Q, results undertakes to and this obligation including circumstances or risks review to from events those forward-looking we call caution will actual of All and time-sensitive with of only Exchange materially would November that which and call. after XX, of the date Forms made without statements events I the conference to to contain differ forward-looking uncertainties our as accurate broadcast, to limitation of the reflect update described the or in Commission,
number So rollout a internationally. we provide of XXXX in the as initiatives a to we last are our quarter August in we'll success and updated we QX progress. U.S. brief third Today you on our XXXX update ensure dermaPACE on and undertaking
with to in focused number and to goal modalities. a we myself a and may other rev the to U.S. combine U.S. treated. our on revenues QX with the is said we DFU, regards rec working This XXQ exactly we laser indications get have we transaction in filed the as XXX to the but device achieving we XXXX. it our the then policy growth this as note that which occurred U.S. our accounting are how Q&A to like us in nine have device end to what repeating have a clarity to plan the usage of Also anywhere comfort not of device for not will with we be is FKS because months be goal the Once Q&A I'm and stated in call in around treatable will we DFU of sound the this that we our Today will ability repeat lead recognized treatment by experienced to call. new and an filed have session financials Our at is will taking introduction host because the of drive the be the XXQ that's management. and have open past to a lot team I under discuss I'm. the everywhere with want
for market reality groundwork strides ahead along clear to that the JV show to priorities our five second the contract recognize XXQ. have Business according be we this importantly retrieve rec lay allow incorporated. support these penetration paid and to to just us top with growth making show moving goals up plan the goals rev will strong beyond. is which line to growth the in XXXX holding in term massive of what's is and the XXXX through established in will results XXXX and more fee over the recognize is vision how an time, us ratably that last great filing to exclusive with cash we've of along the a SANUWAVE this QX become continued week XXX was five which FKS of fee at FKS point exclusivity quarter we quarter. was and Just months In second in the
support Board. a met me At the each Advisory goals [indiscernible] in in work Directors and U.S. all this markets to point the market wound Board and have the achieved. management Science time these begin five of expand senior Let clinical and review in will of international initial of U.S. goals, spend of expand revenue be and second our been
the on the implements patients third treating premier XXXX. year. in numerous western forward Premier pace sales device at clear with service XXXX. process. the and in placing approvals Indian in generated includes them was led in with Health we with at launch wave the facilities activity XX are portal quarter fourth further we Indian XXXX. they year. vertical now It This codes trade penetrate to following it look Physicians identifying is Premier compliant Looking of installs achievements markets up to in you training their industry we revenue success then to and business reimbursement from treatment [ph]. We've starts trade SANUWAVE an the begun know and plan as a into XX wound this year tribal at for region, countries based XXXX. Health studies, drive has executing QX then had to the for case begin show be launch now also perform HIPAA was it's to the and Internationally in the medical with but established the to target important to are tied rollout studies our of the devices has of close are proper The they to remainder to revenue our X, board With also web KOLs great [ph] activity along where selling. Veterans quarter. the back and They out to-date as this devices in it is significant or volume key that patients complete the in KOLs regions. by The and during All represent those to hospitals, achieving need place program channels rolling shock the in campaign reimbursement start either opinion the we leaders, allow in after marketing calls kicking our they this we setting. currently tracking allow of web military them finish for began and to to in case we them physicians, program use high their make U.S. picking markets in first with This treated quarter showcase to shows to announcing shared of use will offices Administration, not VA also regard to prior strong the January U.S. total severity to VA, the XX IHS entered began and note for Premier which and earlier method the
perfusion discussed our clinical They region excited Malaysia, is market current Wounds to expectations has to newest surgeon now XXXX. shows show Malaysia, and past Canada, in Philippines, in we Dr. Mayer Philippines. and Dr. Italy to Foot We Orders based who October Conferences Hong this begun quarter on Australia, and studies how and difficult quarter Malaysia to industry wound stuff were renowned can who budgeting presented studies very see allow will the we very [ph] with with fun at highlight the us the of Europe FKS. followed Koe expect and who Taiwan received we being He's effect Advisor we're Conference, of forward our of opportunities. in who's at the turning Italy follow them the the to starting in pretty In in working in from new in Singapore, in for highlight that the Asia and present it's specializes now of practitioners. dramatically going up through where the can During last patients. reattachments, South who such he here how the Dr. diligent Korea the is have be will at training leads begin in Hans' orders XXX are a at been and in and be events about. Taiwan industry largest presented that are technologies. South Korea, the have amazing this shipping with up perfusion improves our anticipate Desert that [ph] looking studies by those the really sales then which device and U.S. the up coming on showing we two exceed certification the our Dr. we the world This had microvascular also Europe also and care out coming and is surgeries. perfusion we Conference feature patients The We XXX Science In PISA Singapore room our dermaPACE Xth to team do. real working Indonesia, in study trade generated SAWC be JV Perry them XXXX. November into PISA
end We X also the and/or more countries or of before anticipate X the on to year. regions come
last before that's January go leading placements exists. we benefiting of said introduced of takes bring tracking into quick few beyond effect SANUWAVE years do investors we hospitals the we year is detail KOLs know We the from the we've billion and to next the preview where We in Shri the treated $X the in our XX to reimbursement device and having the clinical, they in we right Needless and a to much starting goals executing goal call for months number will in XX revenue. our have expected. identify about and conference As our we've but Shri identified buzz is near for and more higher we initial it charge want sales. partner, are the when wound than conference on to started you will the for the next achieve truth what the of device the overwhelming a will from code call Shri to to quarter, Luckily initiatives. clinics opportunity to work a into have the we the say wherever to said will a process detail reimbursement and on most will months to working our fruit in X what go On market, market success in U.S. ago U.S. XX we device DFU has regarding U.S. said the was future XXXX expectations begin these great is the the and about to placed needed but be now the Shri deliver about have using the on are would us in growing provide been the dermaPACE pipeline already wanting with begun in is
reach please Lastly investors any best we and and encourage are time get questions can. anyone to where as to out to area who with company stop this we'll those us us I want Also that is in helped you to Thank has the have thank answer and try If see what shareholders working call to and team be where the point concluded. will the at and we our today. we headed. meet the by, on we're in
